Alleima (ALLEI) investor relations material

Strategic Direction and Market Positioning

• Focus on profitable growth through targeted capital allocation in five priority segments: medical, nuclear, chemical/petrochemical, hydrogen/renewable energy, and industrial heating, aiming for a 6% CAGR mid-to-long term.

• Continued shift in business mix to grow targeted segments to 45%-50% of sales and reduce industrial to 10%-15% by 2030, with a strong emphasis on value creation and capital efficiency.

• Maintains leading positions in niche markets, such as umbilical tubes for oil and gas, steam generator tubes for nuclear, and medical wire, with significant expansion in APAC and investments in new facilities in Germany, China, Sweden, Japan, Malaysia, the UK, and the US.

• Strategy execution includes both organic growth and selective M&A, especially in medical and industrial heating, with recent acquisitions enhancing capabilities in medical components, high-performance alloys, and aerospace.

• Resilience and reduced volatility achieved by balancing exposure across 10 customer segments and avoiding low-margin volume filling during downturns.

Financial Performance and Capital Allocation

• Revenues for R12 Q3 2025 reached SEK 19,230 million with an adjusted EBIT margin of 9.2%, up from 7.8% in previous years.

• Strong balance sheet and cash generation enable continued investments in growth and efficiency, with annual maintenance CapEx around SEK 400 million and FY 2025 CapEx guidance of SEK ~1,200 million.

• Net debt/equity ratio at -0.02x in Q3 2025, with a financial net cash position of SEK 1.5 billion and undrawn credit facilities of SEK 3 billion.

• Growth CapEx is primarily allocated to high-return segments, with recent investments in nuclear tube capacity, medical wire in Malaysia, and Kanthal expansion in Japan.

• Dividend policy targets 50% of net profit over a business cycle, with robust free operating cash flow despite increased CapEx and working capital impacted by metal prices and geographic shifts.

Innovation, R&D, and Operational Excellence

• Sustained investment in R&D, focusing on advanced materials for demanding applications, such as next-generation nuclear reactors, high-strength umbilicals, and medical devices.

• Product innovation includes new high-nickel alloys, super duplex for heat exchangers, and Kanthal flow heaters enabling electrification and sustainability in industrial processes.

• Operational excellence programs target automation, yield improvement, and cost efficiency, particularly in underperforming units and the Strip division.

• Commercial excellence initiatives include enhanced value selling, salesforce development, and expansion of channel partners to reach smaller customers, especially in knife steel.

• Decentralized accountability and enhanced financial steering models are being implemented to drive performance culture and faster decision-making.